Delay after delay ... after delay. Here's what all the Obamacare extensions and pushbacks mean for you.
For millions of Americans who'll rely on Obamacare, having enough young, healthy participants is essential. Find out why here.
Should you consider buying these four dialysis stocks -- DaVita, Fresenius, NxStage, and Rockwell -- since the Centers for Medicare and Medicaid Services changed its tune on reducing payments to kidney dialysis providers?
Warren Buffett's Berkshire Hathaway added to its position on one stock last quarter: DaVita. Here's what Buffett liked about this dialysis services leader.
AmerisourceBergen is a great growth stock in an industry where growth is usually slow to moderate.
Forget revenue and earnings (at least for a little bit). Here are the key numbers Rockwell Medical investors really need to know.
According to a Manhattan Institute study, five states will see premium costs double under Obamacare. Find out whether your state is one of them.
With nearly seven million new enrollments expected to come through the Obamacare exchanges, some of the bigger insurance providers, including Cigna and Aetna are leaving the door wide open for smaller players like Molina Healthcare to gobble up marke tshare.
The Affordable Care Act is creating a variety of challenges and opportunities for health care companies. Medtronic is embracing a provision designed to reduce re-admissions by expanding into the home monitoring market.
Will Obamacare succeed or fail? It doesn't matter nearly as much to Cigna than it does to insurers like Aetna, UnitedHealth, and WellPoint. Here's why.